Cargando…
A novel Artificial Intelligence-based tool to assess anticholinergic burden: a survey
BACKGROUND: many medications possess anticholinergic activity. Their use is associated with a number of serious adverse effects including cognitive effects. The cumulative anticholinergic effect of medications as assessed by tools such as the anticholinergic burden scale (AchB) can identify people p...
Autores principales: | Secchi, Agostina, Mamayusupova, Hulkar, Sami, Saber, Maidment, Ian, Coulton, Simon, Myint, Phyo Kyaw, Fox, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419503/ https://www.ncbi.nlm.nih.gov/pubmed/36029230 http://dx.doi.org/10.1093/ageing/afac196 |
Ejemplares similares
-
Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC‐Norfolk prospective population‐based cohort study
por: Sanghavi, Ria, et al.
Publicado: (2022) -
Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review
por: Stewart, Carrie, et al.
Publicado: (2021) -
Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study
por: Grossi, Carlota M., et al.
Publicado: (2019) -
Anticholinergic burden measures and older people’s falls risk: a
systematic prognostic review
por: Stewart, Carrie, et al.
Publicado: (2021) -
Anticholinergic drugs and risk of dementia: case-control study
por: Richardson, Kathryn, et al.
Publicado: (2018)